ALL-173 Evolution of Tisagenlecleucel Use for the Treatment of Pediatric and Young Adult Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) Registry Results
Clinical Lymphoma Myeloma and Leukemia(2024)
关键词
ALL,B-ALL,relapsed/refractory,pediatric,young adult,tisagenlecleucel,HSCT
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要